MDT perspectives on the current and emerging second-line treatment options for SCLC

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting. The multidisciplinary team: Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME. For further information please visit: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/